Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Galectins and cancer.

André Danguy1, Isabelle Camby, Robert Kiss

  • 1Laboratory of Histopathology, CP 620, Faculty of Medicine, Université Libre de Bruxelles, 808 Route de Lennik, B-1070, Brussels, Belgium. adanguy@ulb.ac.be

Biochimica Et Biophysica Acta
|September 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of APOC3 Inhibition With Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study.

Circulation·2026
Same author

Pathologic Variability Associated With Phenotypic Differences in Siblings With ACTA1 Myopathy.

Muscle & nerve·2026
Same author

Antibody-mediated LOX-1 inhibition in patients with residual inflammation after myocardial infarction: a randomized phase 2 trial.

Nature medicine·2025
Same author

Editorial: Endocrinology, lipids, and disease: unraveling the links.

Frontiers in endocrinology·2025
Same author

A data-driven journey using results from target-based drug discovery for target deconvolution in phenotypic screening.

RSC medicinal chemistry·2025
Same author

DIY Virtual Chemical Libraries - Novel Starting Points for Drug Discovery.

ACS medicinal chemistry letters·2023
Same journal

Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

Molecular Basis of Disease Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

General Subjects Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

Erratum to 'on the role of exchangeable hydrogen bonds for the kinetics of P680<sup>+·</sup> Q<sub>A</sub> <sup>-·</sup> formation and P680<sup>+·</sup> Pheo<sup>-·</sup> recombination in photosystem II' [Biochim. Biophys. Acta 1276 (1996) 35-44].

Biochimica et biophysica acta·2019
Same journal

Oligomeric state of the light-harvesting complexes B800-850 and B875 from purple bacterium Rubrivivax gelatinosus in detergent solution.

Biochimica et biophysica acta·2019
Same journal

Regulation of pigment content and enzyme activity in the cyanobacterium Nostoc sp. Mac grown in continuous light, a light-dark photoperiod, or darkness.

Biochimica et biophysica acta·2019
See all related articles

Galectins, a protein family, play roles in various cellular processes. Their exact involvement in human cancer development and spread remains under investigation.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Galectins are a conserved protein family with galactose-binding properties.
  • Fourteen galectins are identified in mammals, involved in diverse biological functions.
  • Galectins are implicated in development, cell adhesion, growth regulation, and tumor metastasis.

Purpose of the Study:

  • To review the current understanding of galectin expression in human neoplastic tissues.
  • To discuss the impact of galectins and their binding sites on cancer behavior.

Main Methods:

  • Literature review of studies on galectin expression in human cancers.
  • Analysis of research linking galectin function to neoplastic tissue behavior.

Main Results:

Related Experiment Videos

  • Galectin expression patterns vary across different human cancers.
  • Galectin-binding sites and their modulation influence tumor cell interactions and progression.
  • The precise role of galectins in tumorigenesis and metastasis is complex and context-dependent.

Conclusions:

  • Galectin expression and binding sites are significant factors influencing human cancer behavior.
  • Further research is needed to fully elucidate the therapeutic potential of targeting galectins in oncology.